OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
Konstantinos Arvanitakis, Ioannis Mitroulis, Georgios Germanidis
Cancers (2021) Vol. 13, Iss. 12, pp. 2899-2899
Open Access | Times Cited: 84
Konstantinos Arvanitakis, Ioannis Mitroulis, Georgios Germanidis
Cancers (2021) Vol. 13, Iss. 12, pp. 2899-2899
Open Access | Times Cited: 84
Showing 1-25 of 84 citing articles:
Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases
Agata Buonacera, Benedetta Stancanelli, Michele Colaci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3636-3636
Open Access | Times Cited: 484
Agata Buonacera, Benedetta Stancanelli, Michele Colaci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3636-3636
Open Access | Times Cited: 484
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 330
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 330
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Romain Donné, Amaia Lujambio
Hepatology (2022) Vol. 77, Iss. 5, pp. 1773-1796
Closed Access | Times Cited: 295
Romain Donné, Amaia Lujambio
Hepatology (2022) Vol. 77, Iss. 5, pp. 1773-1796
Closed Access | Times Cited: 295
Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhӓuser, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3778-3778
Open Access | Times Cited: 108
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhӓuser, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3778-3778
Open Access | Times Cited: 108
CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 50
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 50
Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 799-815
Closed Access | Times Cited: 52
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 799-815
Closed Access | Times Cited: 52
Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
Jaafar Khaled, Maria Kopsida, Hans Lennernäs, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 632-632
Open Access | Times Cited: 50
Jaafar Khaled, Maria Kopsida, Hans Lennernäs, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 632-632
Open Access | Times Cited: 50
Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer
Ning Li, Xiaoyu Zhang, Jin Zhou, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114448-114448
Open Access | Times Cited: 49
Ning Li, Xiaoyu Zhang, Jin Zhou, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114448-114448
Open Access | Times Cited: 49
Advances of cancer-associated fibroblasts in liver cancer
Hao Peng, Erwei Zhu, Yewei Zhang
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Hao Peng, Erwei Zhu, Yewei Zhang
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma
Hikmet Akkız
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3941-3941
Open Access | Times Cited: 27
Hikmet Akkız
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3941-3941
Open Access | Times Cited: 27
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 27
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 27
Neutrophils in glioma microenvironment: from immune function to immunotherapy
Chao Sun, Siwen Wang, Zhen Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Chao Sun, Siwen Wang, Zhen Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Neutrophil in the Pancreatic Tumor Microenvironment
Lin Jin, Hong Sun Kim, Jiaqi Shi
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1170-1170
Open Access | Times Cited: 44
Lin Jin, Hong Sun Kim, Jiaqi Shi
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1170-1170
Open Access | Times Cited: 44
Roles of tumor-associated neutrophils in tumor metastasis and its clinical applications
Man Yan, Minying Zheng, Rui Niu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 36
Man Yan, Minying Zheng, Rui Niu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 36
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
Jing‐Houng Wang, Yen‐Yang Chen, Kwong‐Ming Kee, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 343-343
Open Access | Times Cited: 32
Jing‐Houng Wang, Yen‐Yang Chen, Kwong‐Ming Kee, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 343-343
Open Access | Times Cited: 32
Neutrophils: New Critical Regulators of Glioma
Guanyu Wang, Jinpeng Wang, Chaoshi Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Guanyu Wang, Jinpeng Wang, Chaoshi Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2795-2795
Open Access | Times Cited: 19
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2795-2795
Open Access | Times Cited: 19
The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3161-3161
Open Access | Times Cited: 19
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3161-3161
Open Access | Times Cited: 19
γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1381-1381
Open Access | Times Cited: 6
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1381-1381
Open Access | Times Cited: 6
Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization
Gang Peng, Xiaojing Cao, Xiaoyu Huang, et al.
European Journal of Radiology Open (2024) Vol. 12, pp. 100551-100551
Open Access | Times Cited: 5
Gang Peng, Xiaojing Cao, Xiaoyu Huang, et al.
European Journal of Radiology Open (2024) Vol. 12, pp. 100551-100551
Open Access | Times Cited: 5
Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways
Konstantinos Arvanitakis, Stavros P. Papadakos, Georgios Vakadaris, et al.
Hepatoma Research (2024)
Open Access | Times Cited: 5
Konstantinos Arvanitakis, Stavros P. Papadakos, Georgios Vakadaris, et al.
Hepatoma Research (2024)
Open Access | Times Cited: 5
Cancer-associated fibroblast-derived exosomes in cancer progression: a focus on hepatocellular carcinoma
Chou‐Yi Hsu, Abdulrahman T. Ahmed, Safia Obaidur Rab, et al.
Experimental Cell Research (2025), pp. 114424-114424
Closed Access
Chou‐Yi Hsu, Abdulrahman T. Ahmed, Safia Obaidur Rab, et al.
Experimental Cell Research (2025), pp. 114424-114424
Closed Access
Immunity revealed: Stratifying hepatocellular carcinoma for precision immunotherapy
Konstantinos Arvanitakis, Georgios Germanidis
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200939-200939
Closed Access
Konstantinos Arvanitakis, Georgios Germanidis
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200939-200939
Closed Access
A single approach, multiple insights: Harnessing spatial transcriptomics and proteomics to identify novel therapeutic targets of alcohol‐associated hepatitis
Eric Ham, Claudia R. Keating, Wei Qiu
Alcohol Clinical and Experimental Research (2025)
Closed Access
Eric Ham, Claudia R. Keating, Wei Qiu
Alcohol Clinical and Experimental Research (2025)
Closed Access
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma
L. Gramantieri, Annapaola Montagner, Andrea Arleo, et al.
ESMO Open (2025) Vol. 10, Iss. 3, pp. 104289-104289
Open Access
L. Gramantieri, Annapaola Montagner, Andrea Arleo, et al.
ESMO Open (2025) Vol. 10, Iss. 3, pp. 104289-104289
Open Access
